List Of Post By Tag

What I Know Now That I Wish I Knew Then: Anne DeGheest, MedStars and HealthTech Capital
Written by Anne DeGheest // 25 August 2011 // Entrepreneur

The best angel investors are really “mentor capitalists” at heart, investing capital for not just a financial return, but the opportunity to share their experience and networks. They are driven to do whatever it takes: fixing the product bugs, changing market strategy, dedicating themselves to getting the company off the ground, investors, advisors and/or board members.

The entrepreneur’s relationship to such people must be based on openness and honesty: sharing the good, the bad and the ugly. Often entrepreneurs fall in love with their ideas and cannot answer the famous "So what" questions: what is the value proposition? Who make customer decisions? Who pays and why? The entrepreneur has to articulate clearly why there is a large market that has to have this new products now. Proactive investors, advisors and board members can help answer these questions.

Often the right people for these relationships are industry veterans who have built a business in the entrepreneur’s industry from the ground up, and have known failure as well as success. As “business architects”, they can teach the intricacies of market strategy and finance. They often seek both stock for their “sweat equity” and preferred stock for own cash investment. This aligns them with founders and other common shareholders. Properly recruited they can be one of the biggest factors in a business’s success.

MedStars and HealthTech Capital invest in Niveus
Written by Anne DeGheest // 26 July 2011 // Entrepreneur, Angel funding
For the last 2 years, I have been mentoring Brian Fahey, the founder of Niveus who is now closing on a $2 Million series A from major angel groups. 

My angel group, HealthTech Capital, played a key role with our members investing directly around $600,000. By sharing our due diligence with other angel groups, we helped in creating a powerfull value add syndicate.

Continue Reading
FDA drafts mobile medical app regulations
Written by Anne DeGheest // 22 July 2011 // Entrepreneur

Check Brian Dolan thorough review of the new FDA draft for mobile medical applications

As part of its draft guidance the FDA, of course, had to sketch out its very particular definition of a mobile medical app. The agency broke the definition into three parts: mobile platform, mobile app, and mobile medical application. A mobile platform is a commercial off-the-shelf computing platform “with or without wireless connectivity” that is handheld. Mobile apps are software that can be run on a mobile platform or a Web-based software application that is designed for the mobile platform.   Finally, a mobile medical app is one that meets the definition of "device" according to the FD&C Act, but for this set of draft regulation it also must be "used as an accessory to a regulated medical device" or it must "transform a mobile platform into a regulated medical device."

 Apps that would not be regulated and Apps that would be regulated

Health Care Information Technology: Venture's New Darling?
Written by Anne DeGheest // 20 July 2011 // Entrepreneur
As traditional venture-like returns are harder to generate from drug development and medtech plays, some frustrated VCs see new opportunities in health care information technology, an area many have traditionally avoided Paul Bonanos, Start-Up 06/01/2011 

"....With health care costs spiraling upwards, VCs see an opportunity to create businesses via IT to cut costs out of the health care system. Government initiatives such as the Affordable Care Act and the HITECH Act are galvanizing a tech-ready industry that has been slow to adopt new procedures and may provide VCs with potential new buyers for their fledgling companies".

Continue Reading
Angels with green wings: Investors support innovative health-care ventures
Written by Anne DeGheest // 17 April 2011 // Angel funding, Entrepreneur

On April 12, 2011, Mary Beth Hislop from the Los Altos Crier wrote an article about Anne DeGheest's efforts with her new angel group HealthTech Capital:  Health care was a $2.5 trillion industry in 2009 - in 2007, $2.2 trillion. It's a safe bet that amount was higher last year, and will be again in 2011.  So when seasoned angel investor and Los Altos Hills resident Anne DeGheest realized that 80 percent of that money is spent on health-care delivery systems, she saw an opportunity for investors to support innovations designed to reduce the costs of delivering health care. With a master's degree in engineering from the University of Belgium, a master's degree in business administration from Harvard University and 25 years' investing experience with MedStars Ventures Partners, De Gheest launched Los Altos Hills-based HealthTech Capital in June 2010. Unlike other health-care investor groups that focus on funding startup companies for therapeutic drugs or medical devices, HealthTech's goal is to support technological innovations that improve health-care delivery and reduce costs.  "Our sweet spot has minimal or no government regulation oversight by the Food and Drug Administration or centers for Medicare and Medicaid services," DeGheest said.  What makes HealthTech's business model special is that startup support involves more than monetary funding. "(This) is a new private-equity investment model that leverages professional investment management oversight with the collegiality and shared expertise found in organized angel-investor groups," she said.

Continue Reading


© 2011 HealthTech Capital. All Rights Reserved. Designed by Night River